A new pill, tavapadon, has shown potential in easing Parkinson’s symptoms while limiting side effects. In patients taking at ...

Pfizer is facing another setback with its weight-loss pill, danuglipron. The pharmaceutical giant stopped development of the ...

Although the administration method seems ideal for prehospital use, the complexities of stroke assessment — including CT ...

The US Senate Judiciary Committee advanced to the full Senate six bills intended to reduce pharmaceutical prices and enhance ...

Novo Nordisk has signed an exclusive global licensing deal worth up to $2 billion for UBT251, a weight-loss drug developed by China-based The United Laboratories International Holdings Limited.

Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...

Now dermatologists are increasingly prescribing the drug, known generically as minoxidil, in low-dose pills to help men and women maintain or regrow hair. The practice follows several recent ...

Savvy pharma-stock investors know that an oral GLP-1 drug from Novo Nordisk called Rybelsus has been on the market as a ...

Coherus BioSciences is now heavily focused on developing its pipeline, particularly casdozokitug and CHS-114. See why I rate ...

The drug will come in 25 mg, 75 mg, and 150 mg tablets. Starting dosage and titration schedule is based on the patient's body weight. Soleno said diazoxide choline should be available beginning in ...

It's little secret that America has a weight problem. For decades, Americans have embraced and abandoned countless ...

Danuglipron trials involved over 1,400 participants before discontinuation. One asymptomatic liver injury case noted in dose-optimization study. Feel unsure about the market’s next move?